Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

1.3K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.3K
Pigmentation01:19

Pigmentation

5.0K
The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
5.0K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

1.2K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.2K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

1.5K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.5K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.5K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary: Modulation of ASC-derived extracellular vesicles containing cargo that specifically enhances wound healing.

Frontiers in pharmacology·2026
Same author

Quercetin-Arctigenin Co-Treatment Induces Mitochondrial Dysfunction and Apoptotic Cell Death Through Metabolic Stress in Malignant Mesothelioma Cells.

Life (Basel, Switzerland)·2026
Same author

Genistein and Butein as Bioactive Polyphenols: Molecular Targets, Metabolic Regulation, and Mechanistic Insights.

Life (Basel, Switzerland)·2026
Same author

Preventive Effect of Caffeic Acid Phenethyl Ester, an Active Component of Propolis, against TNF-α-Induced Endothelial Dysfunction through the β2-Adrenoceptor-Mediated eNOS/NO Signal Pathway.

Journal of agricultural and food chemistry·2026
Same author

Genistein-Butein Co-Treatment Suppresses Glycolytic Metabolism and Induces Apoptotic Signaling in PC-3 Prostate Cancer Cells.

Current issues in molecular biology·2026
Same author

Dietary Polyphenols Curcumin and Resveratrol Exert Selective Anticancer Effects in Melanoma Cells.

Nutrients·2026
Same journal

Toxicity evaluation and anti-ischemic stroke activity of selected natural extracts in zebrafish.

Biomedical reports·2026
Same journal

Association between tidal volume and mortality in patients without acute respiratory distress syndrome: A systematic review and meta-analysis.

Biomedical reports·2026
Same journal

Clinical and pathological analysis of pediatric patients with primary pulmonary tumors at a single center.

Biomedical reports·2026
Same journal

Cariprazine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder: A case report.

Biomedical reports·2026
Same journal

IL-6/STAT3 signaling pathway-mediated apoptosis induced by medical ozone water in liver cancer: A mechanistic study.

Biomedical reports·2026
Same journal

Exploring the mechanisms of baicalin in diabetic cardiomyopathy: Insights from network pharmacology and experimental validation.

Biomedical reports·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

12.1K

Proton pump inhibitors decrease melanogenesis in melanocytes.

Seung-Hwa Baek1, Sang-Han Lee2

  • 1Department of Food Science and Biotechnology, Kyungpook National University, Daegu 702-701, Republic of Korea.

Biomedical Reports
|September 26, 2015
PubMed
Summary
This summary is machine-generated.

Proton pump inhibitors (PPIs) inhibit melanin synthesis by downregulating key genes in melan-a cells. These findings suggest PPIs may serve as novel agents for skin whitening and treating hyperpigmentation.

Keywords:
anti-melanogenic effectsmelanocytemelanogenesis-associated genesproton pump inhibitorstyrosinase

More Related Videos

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.9K
Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
11:00

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress

Published on: August 31, 2015

8.8K

Related Experiment Videos

Last Updated: Apr 3, 2026

Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

12.1K
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.9K
Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
11:00

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress

Published on: August 31, 2015

8.8K

Area of Science:

  • Biochemistry
  • Dermatology
  • Pharmacology

Background:

  • Proton pump inhibitors (PPIs) are commonly prescribed for gastroesophageal reflux disease.
  • The impact of PPIs on melanogenesis, the process of melanin production, remains largely unexplored.
  • Understanding these effects is crucial for potential dermatological applications.

Purpose of the Study:

  • To investigate the effects of various PPIs on melanogenesis in a mouse melanocyte cell line (melan-a).
  • To assess the impact of PPIs on tyrosinase activity, melanin content, and the expression of melanogenesis-related genes.

Main Methods:

  • Spectrophotometric analysis of tyrosinase and copper-chelating activity.
  • Assessment of melanin content and cell viability in PPI-treated melan-a cells.
  • Quantitative reverse transcription-polymerase chain reaction (RT-PCR) to measure gene expression.

Main Results:

  • Rabeprazole demonstrated potent, dose-dependent inhibition of mushroom tyrosinase (TYR).
  • All tested PPIs exhibited copper-chelating activity.
  • PPI treatment significantly reduced melanin synthesis and downregulated key melanogenesis genes (TYR, TRP-1, TRP-2, MITF) without cytotoxicity.

Conclusions:

  • PPIs inhibit melanin biosynthesis in melan-a cells through the downregulation of melanogenesis-associated genes.
  • The findings suggest a potential therapeutic role for PPIs as skin-whitening agents or in managing hyperpigmentation disorders.